GlassScriptPhysician profile
Greg J Denhaese
NPI 1558357517
$4,401.95
in general payments reported to CMS, 2019-2025
10 companies · $49.47 in 2025
The $49.47 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,252 · 2020: $38.10 · 2021: $47.78 · 2024: $14.77 · 2025: $49.47.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $64.24.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $64.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ge Healthcare | $3,836.39 | 2019 | |
| Boston Scientific Corporation | $350.00 | 2019 | |
| Abbvie INC. | $54.52 | 2019-2020 | |
| Hologic Sales and Service, LLC | $50.18 | 2019-2025 | Myosure Tissue Removal Device |
| Meditrina | $24.47 | 2025 | |
| Astellas Pharma US INC | $23.84 | 2020 | |
| Evofem Biosciences, INC. | $18.55 | 2021 | |
| Janssen Pharmaceuticals, INC | $16.89 | 2021 | |
| Gynesonics, INC. | $14.77 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Therapeuticsmd, INC. | $12.34 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Greg Denhaese listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.